Insight Molecular Diagnostics (IMDX) Shares Outstanding (2020 - 2025)
Insight Molecular Diagnostics (IMDX) has disclosed Shares Outstanding for 6 consecutive years, with $28.7 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding rose 64.34% to $28.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.7 million through Dec 2025, up 64.34% year-over-year, with the annual reading at $28.7 million for FY2025, 64.34% up from the prior year.
- Shares Outstanding hit $28.7 million in Q4 2025 for Insight Molecular Diagnostics, roughly flat from $28.6 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $92.2 million in Q3 2021 to a low of $5000.0 in Q3 2023.
- Historically, Shares Outstanding has averaged $23.8 million across 5 years, with a median of $10.8 million in 2024.
- Biggest five-year swings in Shares Outstanding: plummeted 99.99% in 2022 and later soared 571880.0% in 2025.
- Year by year, Shares Outstanding stood at $4.6 million in 2021, then grew by 28.62% to $5.9 million in 2022, then plummeted by 99.92% to $5000.0 in 2023, then soared by 348960.0% to $17.5 million in 2024, then skyrocketed by 64.34% to $28.7 million in 2025.
- Business Quant data shows Shares Outstanding for IMDX at $28.7 million in Q4 2025, $28.6 million in Q3 2025, and $28.6 million in Q2 2025.